Concepedia

Gershon Y. Locker

GY

41

Publications

10.8K

Citations

26

H-Index

1979

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

University of Chicago

Northwestern University

NorthShore University HealthSystem

AstraZeneca (United States)

Gershon Y. Locker is an author at AstraZeneca (United Kingdom) specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1979–2022

41

Publications

41

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

Anthony Howell, Jack Cuzick, M Baum et al. · The Lancet · 2005 · 2.3K citations

, , +8

Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer

Talia Golan, Pascal Hammel, Michele Reni et al. · New England Journal of Medicine · 2019 · 2.1K citations · Full text

ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer

Gershon Y. Locker, Stanley R. Hamilton, Jules E. Harris et al. · Journal of Clinical Oncology · 2006 · 1.6K citations

2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*

Robert C. Bast, Peter M. Ravdin, Daniel F. Hayes et al. · Journal of Clinical Oncology · 2001 · 884 citations

Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen Metabolites

James H. Doroshow, Gershon Y. Locker, Charles E. Myers · Journal of Clinical Investigation · 1980 · 700 citations · Full text

, , +17

Rows per page

1–5 of 41